OGI vs. ACB, CGC, CRON, SNDL, TLRY, VFF, SANA, AKBA, PHAT, and AMLX
Should you be buying Organigram Global stock or one of its competitors? The main competitors of Organigram Global include Aurora Cannabis (ACB), Canopy Growth (CGC), Cronos Group (CRON), SNDL (SNDL), Tilray Brands (TLRY), Village Farms International (VFF), Sana Biotechnology (SANA), Akebia Therapeutics (AKBA), Phathom Pharmaceuticals (PHAT), and Amylyx Pharmaceuticals (AMLX).
Organigram Global vs. Its Competitors
Aurora Cannabis (NASDAQ:ACB) and Organigram Global (NASDAQ:OGI) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, institutional ownership, dividends, profitability, valuation, media sentiment and analyst recommendations.
Aurora Cannabis has a beta of 1.91, indicating that its stock price is 91% more volatile than the S&P 500. Comparatively, Organigram Global has a beta of 1.49, indicating that its stock price is 49% more volatile than the S&P 500.
47.6% of Aurora Cannabis shares are owned by institutional investors. Comparatively, 34.6% of Organigram Global shares are owned by institutional investors. 0.0% of Aurora Cannabis shares are owned by insiders. Comparatively, 0.1% of Organigram Global shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
In the previous week, Organigram Global had 2 more articles in the media than Aurora Cannabis. MarketBeat recorded 3 mentions for Organigram Global and 1 mentions for Aurora Cannabis. Organigram Global's average media sentiment score of 0.91 beat Aurora Cannabis' score of 0.00 indicating that Organigram Global is being referred to more favorably in the news media.
Organigram Global has a net margin of 2.86% compared to Aurora Cannabis' net margin of -5.66%. Aurora Cannabis' return on equity of -1.49% beat Organigram Global's return on equity.
Aurora Cannabis has higher revenue and earnings than Organigram Global. Aurora Cannabis is trading at a lower price-to-earnings ratio than Organigram Global, indicating that it is currently the more affordable of the two stocks.
Summary
Aurora Cannabis beats Organigram Global on 9 of the 16 factors compared between the two stocks.
Get Organigram Global News Delivered to You Automatically
Sign up to receive the latest news and ratings for OGI and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding OGI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Organigram Global Competitors List
Related Companies and Tools
This page (NASDAQ:OGI) was last updated on 9/4/2025 by MarketBeat.com Staff
Free OGI Stock Alerts